Recent data from the Central Drugs Standard Control Organization notes that the approval process for new drugs can take between 12 to 24 months, leading to delays in product launches
Comparison of breath- and blood-alcohol concentrations in a controlled drinking study
Whether its a post-Christmas or pre-Easter effect, chocolate became the primary snack choice for GLP-1 users during Q1 2025
Dropout was higher in the 12 mg arm than in the 9 mg arm, reinforcing a pattern already visible in Phase 2: the marginal efficacy gain from pushing to 12 mg comes at real tolerability cost
Efficacy and safety of co-administered once-weekly cagrilintide 2.4 mg with once-weekly semaglutide 2.4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
Genetic Predictors of GLP1 Receptor Agonist Weight Loss and Side Effects. Nature , Apr